Gilead Sciences Inc (NASDAQ:GILD)

77.12
Delayed Data
As of Jul 18
 -0.08 / -0.10%
Today’s Change
64.27
Today|||52-Week Range
89.54
+7.65%
Year-to-Date

Today’s Trading

Previous close77.20
Today’s open77.09
Day’s range76.82 - 77.78
Volume5,186,798
Average volume (3 months)7,035,369
Market cap$87.2B
Data as of 4:15pm ET, 07/18/2018

Growth & Valuation

Earnings growth (last year)-64.69%
Earnings growth (this year)-30.28%
Earnings growth (next 5 years)-3.45%
Revenue growth (last year)-13.79%
P/E ratio29.3
Price/Sales3.62
Price/Book4.29

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.12-0.58%
BIIBBiogen+3.53+0.99%
ILMNIllumina Inc+1.79+0.59%
----
Data as of 4:15pm ET, 07/18/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$1.55
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts